Ranger Investment Management Portfolio holdings
Ranger Investment Management runs long-only portfolios of small and micro cap stocks, with no short selling or leverage. Its managers pick stocks of growth-oriented companies through bottom-up research on individual businesses, and its portfolios are concentrated, with 30 to 60 holdings. The firm began operating in 2002 and advises two mutual funds, one for small caps and one for micro caps, both named Ranger. Its managers took a controlling stake from Ranger Capital Group in a management buyout backed by Kudu Investment Management. Its clients include pension plans, insurers, foundations, endowments, mutual funds and high net worth individuals.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Infrastructure Group
CDNL
|
+$20.3M |
| 2 |
Krystal Biotech
KRYS
|
+$12.7M |
| 3 |
Protagonist Therapeutics
PTGX
|
+$11.7M |
| 4 |
Texas Capital Bancshares
TCBI
|
+$10.4M |
| 5 |
Matador Resources
MTDR
|
+$10.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aaon
AAON
|
+$30.6M |
| 2 |
Pegasystems
PEGA
|
+$26.2M |
| 3 |
SharkNinja
SN
|
+$24.6M |
| 4 |
WillScot Mobile Mini Holdings
WSC
|
+$24.1M |
| 5 |
Jones Lang LaSalle
JLL
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.73% |
| 2 | Industrials | 20.2% |
| 3 | Technology | 17.98% |
| 4 | Energy | 10.65% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Ligand Pharmaceuticals
LGND
$6.12B
| $58M | 5.44% |
185,650
-71,946
| -28% | -$21.3M |
2024 Q1
10 quarters
|
|
2
PDF Solutions
PDFS
$1.59B
| $38.3M | 3.59% |
749,665
-399,982
| -35% | -$19.5M |
2020 Q1
26 quarters
|
|
3
Willdan Group
WLDN
$1.01B
| $27.6M | 2.59% |
372,946
+97,755
| +36% | +$7.74M |
2026 Q1
2 quarters
|
|
4
Solaris Energy Infrastructure
SEI
$3.8B
| $27.1M | 2.54% |
380,235
-203,498
| -35% | -$12.4M |
2025 Q3
4 quarters
|
|
5
Warby Parker
WRBY
$3.17B
| $26.9M | 2.52% |
968,490
-51,574
| -5% | -$1.34M |
2025 Q2
5 quarters
|
|
6
Excelerate Energy
EE
$1.16B
| $26.7M | 2.5% |
830,596
-81,704
| -9% | -$3.08M |
2022 Q3
16 quarters
|
|
7
Oceaneering
OII
$3.41B
| $24M | 2.25% |
548,989
-228,654
| -29% | -$10.9M |
2024 Q2
9 quarters
|
|
8
Triumph Financial Inc
TFIN
$1.46B
| $22M | 2.07% |
367,355
-116,455
| -24% | -$8.46M |
2019 Q2
29 quarters
|
|
9
UL Solutions
ULS
$15.9B
| $21.1M | 1.98% |
321,875
-96,325
| -23% | -$7.55M |
2024 Q4
7 quarters
|
|
10
Ormat Technologies
ORA
$5.65B
| $20.7M | 1.94% |
226,005
+1,909
| +0.9% | +$197K |
2026 Q1
2 quarters
|
|
11
Stevanato
STVN
$3.71B
| $19.9M | 1.87% |
948,353
-238,022
| -20% | -$4.92M |
2024 Q4
7 quarters
|
|
12
HealthEquity
HQY
$8.57B
| $19.6M | 1.84% |
221,323
-97,930
| -31% | -$9.6M |
2024 Q2
9 quarters
|
|
13
ANI Pharmaceuticals
ANIP
$1.53B
| $19.5M | 1.83% |
268,628
-74,522
| -22% | -$5.74M |
2017 Q1
38 quarters
|
|
14
Casella Waste Systems
CWST
$6.25B
| $18.7M | 1.75% |
232,377
-98,083
| -30% | -$8.96M |
2022 Q3
16 quarters
|
|
15
Chime Financial
CHYM
$12B
| $18.5M | 1.73% |
693,610
-495,051
| -42% | -$13.7M |
2025 Q4
3 quarters
|
|
16
Simpson Manufacturing
SSD
$7.98B
| $18.3M | 1.72% |
107,354
-44,480
| -29% | -$8.26M |
2024 Q3
8 quarters
|
|
17
Saia
SAIA
$8.86B
| $17.8M | 1.67% |
53,416
-11,249
| -17% | -$4.21M |
2014 Q1
50 quarters
|
|
18
LeMaitre Vascular
LMAT
$1.85B
| $17.8M | 1.67% |
215,502
-3,805
| -2% | -$337K |
2017 Q2
37 quarters
|
|
19
Federal Signal
FSS
$6.92B
| $17.4M | 1.63% |
157,135
-22,293
| -12% | -$2.67M |
2023 Q2
13 quarters
|
|
|
20
SharkNinja
SN
$31.4B
| $17.1M | 1.6% |
94,945
-145,698
| -61% | -$24.6M |
2025 Q4
3 quarters
|
|
21
Mesa Laboratories
MLAB
$718M
| $17.1M | 1.6% |
131,431
-42,557
| -24% | -$4.83M |
2014 Q3
48 quarters
|
|
22
Paylocity
PCTY
$9.03B
| $16.9M | 1.59% |
118,718
-52,544
| -31% | -$7.35M |
2024 Q2
9 quarters
|
|
23
nCino
NCNO
$2.4B
| $16.8M | 1.58% |
926,529
-48,526
| -5% | -$953K |
2024 Q4
7 quarters
|
|
24
Openlane
OPLN
$4.17B
| $16.6M | 1.56% |
486,465
+46,455
| +11% | +$1.72M |
2026 Q2
1 quarter
|
|
|
25
Cardinal Infrastructure Group
CDNL
$312M
| $16.3M | 1.53% |
531,625
+406,698
| +326% | +$20.3M |
2026 Q2
1 quarter
|
|
Similar funds
Ranger Investment Management's Q3 2026 Portfolio in Review
As of Q3 2026, Ranger Investment Management held 96 positions worth $1.07B, down 33% from $1.58B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Ranger Investment Management withdrew a net $358M in Q3 2026, closing 11 positions and reducing 59 holdings. Its most notable exit was Aaon, an estimated $30.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 20% a quarter earlier, followed by Industrials and Technology.
Against the trend, Ranger Investment Management opened a new position in Krystal Biotech worth $12.2M.
- Ranger Investment Management's largest Q3 2026 buy was Krystal Biotech: 36,557 shares worth $12.2M.
- Ranger Investment Management added most to Cardinal Infrastructure Group in Q3 2026, an estimated $20.3M increase.
- Ranger Investment Management's biggest Q3 2026 reduction was SharkNinja, cutting an estimated $24.6M.
- Ranger Investment Management fully exited Aaon in Q3 2026, selling an estimated $30.6M.
- Ranger Investment Management's ten largest holdings make up 27% of its $1.07B portfolio in Q3 2026.
- Ranger Investment Management opened 13 new positions and closed 11 in Q3 2026.
- Ranger Investment Management's portfolio value fell 33% quarter-over-quarter to $1.07B.
Based on Ranger Investment Management's 13F filing for Q3 2026, filed 6 Nov 2026.